Although none of the earlier studies were able to show that loss of expression of RPRM could influence overall survival in gastric cancer, our group has recently found that loss of RPRM expression does confer a worse prognosis only when accompanied with overexpression of Survivin, a well establish oncogene in gastric cancer [50,53]. The gene discussed is BIRC5; the disease is gastric cancer.